{"id":"https://openalex.org/W1998218836","doi":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","title":"Plasmin\u2010a2\u2010antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis","display_name":"Plasmin\u2010a2\u2010antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis","alternate_titles":[],"publication_year":1984,"publication_date":"1984-04-01","ids":{"openalex":"https://openalex.org/W1998218836","doi":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","mag":"1998218836","pmid":"https://pubmed.ncbi.nlm.nih.gov/6201189"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2141.1984.tb02179.x","doi":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998218836"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110070183","display_name":"N. A. Booth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N. A. Booth","raw_affiliation_strings":["Department of Medicine, University of Aberdeen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Aberdeen","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071598625","display_name":"Bruce Bennett","orcid":"https://orcid.org/0000-0002-4228-0149","observed_orcids":["https://orcid.org/0000-0002-4228-0149"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"B. Bennett","raw_affiliation_strings":["Department of Medicine, University of Aberdeen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Aberdeen","institution_ids":["https://openalex.org/I195460627"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071598625"],"corresponding_institution_ids":["https://openalex.org/I195460627"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.0713,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.75126339,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"56","issue":"4","first_page":"545","last_page":"556"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11116","display_name":"Trauma, Hemostasis, Coagulopathy, Resuscitation","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/2706","display_name":"Critical Care and Intensive Care Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasmin-antiplasmin-complex","display_name":"plasmin-antiplasmin complex","score":0.921999990940094},{"id":"https://openalex.org/keywords/alpha2-antiplasmin","display_name":"alpha2-antiplasmin","score":0.8740000128746033},{"id":"https://openalex.org/keywords/plasmin","display_name":"plasmin","score":0.699999988079071},{"id":"https://openalex.org/keywords/fibrinolysis","display_name":"fibrinolysis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/bleeding-disorders","display_name":"bleeding disorders","score":0.9369999766349792},{"id":"https://openalex.org/keywords/thrombolysis","display_name":"thrombolysis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/urokinase-type-plasminogen-activator","display_name":"urokinase","score":1.0},{"id":"https://openalex.org/keywords/disseminated-intravascular-coagulation","display_name":"disseminated intravascular coagulation","score":1.0},{"id":"https://openalex.org/keywords/tranexamic-acid","display_name":"tranexamic acid","score":0.9549999833106995},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.9359999895095825},{"id":"https://openalex.org/keywords/alpha-2-macroglobulin","display_name":"alpha2-macroglobulin","score":0.984000027179718},{"id":"https://openalex.org/keywords/two-dimensional-immunoelectrophoresis","display_name":"two-dimensional immunoelectrophoresis","score":0.9490000009536743}],"concepts":[{"id":"https://openalex.org/C2776825266","wikidata":"https://www.wikidata.org/wiki/Q1410794","display_name":"Fibrinolysis","level":2,"score":0.9025734066963196},{"id":"https://openalex.org/C2781071845","wikidata":"https://www.wikidata.org/wiki/Q21173374","display_name":"Plasmin","level":3,"score":0.847791850566864},{"id":"https://openalex.org/C2779637338","wikidata":"https://www.wikidata.org/wiki/Q418666","display_name":"Tranexamic acid","level":3,"score":0.7529058456420898},{"id":"https://openalex.org/C2778734968","wikidata":"https://www.wikidata.org/wiki/Q823027","display_name":"Disseminated intravascular coagulation","level":2,"score":0.6561665534973145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.615725040435791},{"id":"https://openalex.org/C2776892390","wikidata":"https://www.wikidata.org/wiki/Q7119591","display_name":"Urokinase","level":2,"score":0.5850157141685486},{"id":"https://openalex.org/C2779026020","wikidata":"https://www.wikidata.org/wiki/Q416336","display_name":"Antithrombin","level":3,"score":0.5286959409713745},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.5035039782524109},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49180129170417786},{"id":"https://openalex.org/C52543561","wikidata":"https://www.wikidata.org/wiki/Q22680187","display_name":"alpha-2-Macroglobulin","level":3,"score":0.47761791944503784},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4704904556274414},{"id":"https://openalex.org/C2779390175","wikidata":"https://www.wikidata.org/wiki/Q855786","display_name":"Immunoelectrophoresis","level":3,"score":0.42594683170318604},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3354475796222687},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.31463491916656494},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.309600293636322},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.28024131059646606},{"id":"https://openalex.org/C2781054842","wikidata":"https://www.wikidata.org/wiki/Q6725283","display_name":"Macroglobulin","level":2,"score":0.22915306687355042},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19583532214164734},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.15843495726585388},{"id":"https://openalex.org/C2991743468","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Blood loss","level":2,"score":0.13066378235816956},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.06859269738197327}],"mesh":[{"descriptor_ui":"D000037","descriptor_name":"Abruptio Placentae","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000933","descriptor_name":"Antifibrinolytic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000979","descriptor_name":"alpha-2-Antiplasmin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D001778","descriptor_name":"Blood Coagulation Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004211","descriptor_name":"Disseminated Intravascular Coagulation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005341","descriptor_name":"Fibrinolysin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D005342","descriptor_name":"Fibrinolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007123","descriptor_name":"Immunoelectrophoresis, Two-Dimensional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011247","descriptor_name":"Pregnancy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014568","descriptor_name":"Urokinase-Type Plasminogen Activator","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2141.1984.tb02179.x","doi":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2141.1984.tb02179.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:6201189","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6201189","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W210701385","https://openalex.org/W1514531933","https://openalex.org/W1969537125","https://openalex.org/W2017528784","https://openalex.org/W2052151271","https://openalex.org/W2065800083","https://openalex.org/W2080572101","https://openalex.org/W2106534126","https://openalex.org/W2109749058","https://openalex.org/W2122038339","https://openalex.org/W2130024242","https://openalex.org/W2147461627","https://openalex.org/W2395871307","https://openalex.org/W2407866941","https://openalex.org/W2412729631","https://openalex.org/W2414051303","https://openalex.org/W2944870346","https://openalex.org/W4297944765"],"related_works":["https://openalex.org/W2122038339","https://openalex.org/W2530208607","https://openalex.org/W2461295276","https://openalex.org/W2355684066","https://openalex.org/W2093773984","https://openalex.org/W2443144609","https://openalex.org/W2395244140","https://openalex.org/W2883653968","https://openalex.org/W2147461627","https://openalex.org/W45630280"],"abstract_inverted_index":{"A":[0],"two-dimensional":[1],"immunoelectrophoresis":[2],"(2DIEP)":[3],"method":[4,109],"detects":[5],"plasmin":[6,62],"complexed":[7,99],"to":[8,139],"its":[9],"major":[10],"inhibitor,":[11],"alpha":[12,120],"2-antiplasmin,":[13],"in":[14,16,88,94,110,128],"plasma":[15,127],"the":[17,49,52,65,72,78,129],"blood":[18,53,68],"of":[19,29,40,45,48,67,77,113,119,126],"patients":[20,93,115,130],"during":[21],"(a)":[22],"thrombolytic":[23],"therapy":[24,83],"with":[25,34,100,116,132],"urokinase,":[26],"(b)":[27],"episodes":[28,39],"disseminated":[30],"intravascular":[31],"coagulation":[32],"(DIC)":[33],"active":[35,61],"fibrinolysis,":[36],"and":[37,56],"(c)":[38],"fibrinolytic":[41],"haemorrhage":[42],"without":[43,86],"evidence":[44],"DIC.":[46,117],"Clearance":[47],"complexes":[50,79],"from":[51],"is":[54],"rapid":[55],"their":[57],"detection":[58],"thus":[59],"implies":[60],"generation":[63],"at":[64],"time":[66],"sampling":[69],"or":[70],"within":[71],"preceding":[73],"24":[74],"h.":[75],"Abolition":[76],"using":[80,105],"tranexamic":[81],"acid":[82],"allowed":[84],"surgery":[85],"bleeding":[87],"two":[89,112],"previously":[90],"grossly":[91],"haemorrhagic":[92],"group":[95],"(c).":[96],"Antithrombin":[97],"III":[98],"activated":[101],"procoagulants":[102],"was":[103],"detected":[104,123],"a":[106],"similar":[107],"2DIEP":[108,125],"only":[111],"four":[114],"Abnormalities":[118],"2-macroglobulin":[121],"were":[122],"on":[124],"studied":[131],"proteolytic":[133],"disorders;":[134],"these":[135],"did":[136],"not":[137],"appear":[138],"reflect":[140],"complex":[141],"formation.":[142]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998218836","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
